Robert  Best  to  United States
                            
                            
                                This is a "connection" page, showing publications  Robert  Best  has written about  United States.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.264
         
        
        
     
 
    
        
        - 
            Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2022 03; 24(3):509-511.
            
            
                Score: 0.081
             
- 
            Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023 02; 25(2):100336.
            
            
                Score: 0.022
             
- 
            Stem cells and the man on the moon: should we go there from here? Am J Bioeth. 2002; 2(1):37-9.
            
            
                Score: 0.020
             
- 
            Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020. J Med Screen. 2021 12; 28(4):405-410.
            
            
                Score: 0.020
             
- 
            Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784.
            
            
                Score: 0.018
             
- 
            Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020 03; 22(3):462-474.
            
            
                Score: 0.017
             
- 
            Response to Knoppers et al. Genet Med. 2019 10; 21(10):2403.
            
            
                Score: 0.017
             
- 
            Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations. Genet Med. 2019 10; 21(10):2285-2292.
            
            
                Score: 0.017
             
- 
            Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019 04; 21(4):769-771.
            
            
                Score: 0.016
             
- 
            Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016 10; 18(10):1056-65.
            
            
                Score: 0.014
             
- 
            Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States? Genet Med. 2015 Nov; 17(11):897-900.
            
            
                Score: 0.013
             
- 
            Ethical issues in genetic counseling: a comparison of M.S. counselor and medical geneticist perspectives. J Genet Couns. 1992 Mar; 1(1):19-30.
            
            
                Score: 0.010